Lindskov J
Acta Med Scand. 1982;212(5):303-8.
The quantitative liver function, measured by the galactose elimination capacity (GEC), was determined repeatedly in 44 patients with cirrhosis during the course of the disease. After a median observation period of 57 months (range 28-85) 17 had died from liver insufficiency. GEC was found to be of prognostic value, as classification of the patient series on the basis of the median value of two extreme prognostic groups indicated that the survival of patients with GEC greater than 1.37 mmol . min-1 at entry was significantly larger than of patients with GEC below that value (p less than 0.05). The prognostic values of serum albumin and prothrombin were of the same order of magnitude. At repeated examinations during the course of the disease, the survivors always had higher GEC values than those who died from liver insufficiency. Among those who survived and those who died there were patients with both increasing and decreasing GEC values, but no significant changes were observed within the groups. The individual changes in GEC can result from changes in the balance between liver cell necrosis and regeneration, but the possibility cannot be excluded that changes are due to methodological problems in the determination of the quantitative liver function as measured by GEC.
通过半乳糖清除能力(GEC)测定的定量肝功能,在44例肝硬化患者的病程中进行了多次测定。在中位观察期57个月(范围28 - 85个月)后,17例患者死于肝功能不全。发现GEC具有预后价值,因为根据两个极端预后组的中位值对患者系列进行分类表明,入院时GEC大于1.37 mmol·min⁻¹的患者生存率显著高于GEC低于该值的患者(p < 0.05)。血清白蛋白和凝血酶原的预后价值处于同一数量级。在疾病过程中的重复检查中,存活患者的GEC值始终高于死于肝功能不全的患者。在存活者和死亡者中,都有GEC值升高和降低的患者,但组内未观察到显著变化。GEC的个体变化可能源于肝细胞坏死与再生平衡的变化,但也不能排除这些变化是由于通过GEC测定定量肝功能时的方法学问题所致。